| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 1.28e-08 | 37 | 88 | 6 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 1.52e-08 | 38 | 88 | 6 | GO:0070001 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 1.13e-07 | 11 | 88 | 4 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 3.41e-07 | 14 | 88 | 4 | GO:0003964 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 1.99e-06 | 21 | 88 | 4 | GO:0035613 | |
| GeneOntologyMolecularFunction | dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity | 1.92e-05 | 2 | 88 | 2 | GO:0106073 | |
| GeneOntologyMolecularFunction | endopeptidase activity | ERVK-6 ERAP2 GZMK ERVK-8 ERVK-18 ERVK-7 ERVK-25 ERVK-10 USP1 CTSZ | 1.95e-05 | 430 | 88 | 10 | GO:0004175 |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 2.08e-05 | 37 | 88 | 4 | GO:0016891 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 2.32e-05 | 38 | 88 | 4 | GO:0034061 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 4.99e-05 | 46 | 88 | 4 | GO:0016893 | |
| GeneOntologyMolecularFunction | peptidase activity | ERVK-6 ERAP2 GZMK ERVK-8 ERVK-18 ERVK-7 ERVK-25 ERVK-10 AGBL2 USP1 CTSZ | 1.39e-04 | 654 | 88 | 11 | GO:0008233 |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 2.00e-04 | 26 | 88 | 3 | GO:0005248 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity involved in cardiac muscle cell action potential | 2.85e-04 | 6 | 88 | 2 | GO:0086006 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 4.11e-04 | 79 | 88 | 4 | GO:0004521 | |
| GeneOntologyMolecularFunction | U3 snoRNA binding | 1.03e-03 | 11 | 88 | 2 | GO:0034511 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 1.06e-03 | 262 | 88 | 6 | GO:0140097 | |
| GeneOntologyMolecularFunction | sodium channel activity | 1.56e-03 | 52 | 88 | 3 | GO:0005272 | |
| GeneOntologyBiologicalProcess | DNA integration | 2.05e-07 | 13 | 87 | 4 | GO:0015074 | |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 1.76e-06 | 48 | 87 | 5 | GO:0000731 | |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 2.66e-05 | 83 | 87 | 5 | GO:0006278 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 4.86e-05 | 17 | 89 | 3 | GO:0001518 | |
| GeneOntologyCellularComponent | C-fiber | 1.07e-04 | 4 | 89 | 2 | GO:0044299 | |
| GeneOntologyCellularComponent | sodium channel complex | 2.52e-04 | 29 | 89 | 3 | GO:0034706 | |
| HumanPheno | Elevated circulating amyloid A concentration | 2.31e-05 | 2 | 25 | 2 | HP:0033332 | |
| Domain | Na_channel_asu | 9.23e-06 | 10 | 81 | 3 | IPR001696 | |
| Domain | Na_trans_assoc | 9.23e-06 | 10 | 81 | 3 | IPR010526 | |
| Domain | Na_trans_assoc | 9.23e-06 | 10 | 81 | 3 | PF06512 | |
| Domain | Alg10 | 1.86e-05 | 2 | 81 | 2 | IPR016900 | |
| Domain | DIE2_ALG10 | 1.86e-05 | 2 | 81 | 2 | PF04922 | |
| Domain | Channel_four-helix_dom | 1.09e-04 | 57 | 81 | 4 | IPR027359 | |
| Domain | - | 1.09e-04 | 57 | 81 | 4 | 1.20.120.350 | |
| Domain | Ion_trans_dom | 1.53e-03 | 114 | 81 | 4 | IPR005821 | |
| Domain | Ion_trans | 1.53e-03 | 114 | 81 | 4 | PF00520 | |
| Domain | PI3/4_kinase_CS | 1.88e-03 | 15 | 81 | 2 | IPR018936 | |
| Domain | - | 2.14e-03 | 16 | 81 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 2.14e-03 | 16 | 81 | 2 | SM00146 | |
| Domain | Gal_Oxase/kelch_b-propeller | 2.14e-03 | 59 | 81 | 3 | IPR011043 | |
| Domain | NAD/diacylglycerol_kinase | 2.42e-03 | 17 | 81 | 2 | IPR016064 | |
| Domain | PI3/4_kinase_cat_dom | 2.72e-03 | 18 | 81 | 2 | IPR000403 | |
| Domain | PI3_PI4_kinase | 2.72e-03 | 18 | 81 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_3 | 2.72e-03 | 18 | 81 | 2 | PS50290 | |
| Domain | PI3_4_KINASE_1 | 2.72e-03 | 18 | 81 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 2.72e-03 | 18 | 81 | 2 | PS00916 | |
| Domain | - | 3.25e-03 | 333 | 81 | 6 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 3.34e-03 | 335 | 81 | 6 | IPR015943 | |
| Domain | CRAL_TRIO | 3.70e-03 | 21 | 81 | 2 | PF00650 | |
| Domain | DAPIN | 4.06e-03 | 22 | 81 | 2 | PS50824 | |
| Domain | PYRIN | 4.06e-03 | 22 | 81 | 2 | PF02758 | |
| Domain | DAPIN | 4.06e-03 | 22 | 81 | 2 | IPR004020 | |
| Domain | PYRIN | 4.06e-03 | 22 | 81 | 2 | SM01289 | |
| Domain | TPR-contain_dom | 4.12e-03 | 150 | 81 | 4 | IPR013026 | |
| Domain | - | 4.43e-03 | 23 | 81 | 2 | 3.40.525.10 | |
| Domain | SEC14 | 5.22e-03 | 25 | 81 | 2 | SM00516 | |
| Domain | WD40_repeat_CS | 5.64e-03 | 164 | 81 | 4 | IPR019775 | |
| Domain | TPR_REGION | 5.77e-03 | 165 | 81 | 4 | PS50293 | |
| Domain | TPR | 5.77e-03 | 165 | 81 | 4 | PS50005 | |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 6.47e-08 | 4 | 89 | 3 | 10469592 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 1.61e-07 | 94 | 89 | 6 | 21542922 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 1.61e-07 | 5 | 89 | 3 | 12629516 | |
| Pubmed | 1.35e-06 | 9 | 89 | 3 | 16382098 | ||
| Pubmed | 3.50e-06 | 12 | 89 | 3 | 20062060 | ||
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 4.45e-06 | 256 | 89 | 7 | 33397691 | |
| Pubmed | A common genetic variant within SCN10A modulates cardiac SCN5A expression. | 6.48e-06 | 2 | 89 | 2 | 24642470 | |
| Pubmed | Heat-resistant action potentials require TTX-resistant sodium channels NaV1.8 and NaV1.9. | 6.48e-06 | 2 | 89 | 2 | 29970412 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 24144460 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 15047701 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 28450535 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 31534133 | ||
| Pubmed | Mutations in SCN10A are responsible for a large fraction of cases of Brugada syndrome. | 6.48e-06 | 2 | 89 | 2 | 24998131 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 24719102 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 24360055 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 32330377 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 18399542 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 31292628 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 19931571 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 34930944 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 16857712 | ||
| Pubmed | The Nav1.9 channel is a key determinant of cold pain sensation and cold allodynia. | 6.48e-06 | 2 | 89 | 2 | 25959819 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 19426868 | ||
| Pubmed | Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity. | 6.48e-06 | 2 | 89 | 2 | 11672541 | |
| Pubmed | Kif26b, a kinesin family gene, regulates adhesion of the embryonic kidney mesenchyme. | 8.86e-06 | 16 | 89 | 3 | 20439720 | |
| Pubmed | An enhancer cluster controls gene activity and topology of the SCN5A-SCN10A locus in vivo. | 1.29e-05 | 18 | 89 | 3 | 31666509 | |
| Pubmed | 1.29e-05 | 18 | 89 | 3 | 18664271 | ||
| Pubmed | PDCD4 interacting with PIK3CB and CTSZ promotes the apoptosis of multiple myeloma cells. | 1.94e-05 | 3 | 89 | 2 | 39190024 | |
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 24303013 | ||
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 30395542 | ||
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 38999942 | ||
| Pubmed | The KBTBD6/7-DRD2 axis regulates pituitary adenoma sensitivity to dopamine agonist treatment. | 1.94e-05 | 3 | 89 | 2 | 32572597 | |
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 25998140 | ||
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 23098854 | ||
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 18710790 | ||
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 10516026 | ||
| Pubmed | N-cadherin regulates cytoskeletally associated IQGAP1/ERK signaling and memory formation. | 1.94e-05 | 3 | 89 | 2 | 17785185 | |
| Pubmed | ABCB5 is a limbal stem cell gene required for corneal development and repair. | 1.94e-05 | 3 | 89 | 2 | 25030174 | |
| Pubmed | Yield of peripheral sodium channels gene screening in pure small fibre neuropathy. | 1.94e-05 | 3 | 89 | 2 | 30554136 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | ARHGEF40 LMF2 GRAMD1A NUP133 DGKE TMEM214 EXT2 PRKDC UNC45A TBL3 SLC27A4 | 2.89e-05 | 942 | 89 | 11 | 31073040 |
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 21162133 | ||
| Pubmed | Genome-wide association studies of the PR interval in African Americans. | 3.87e-05 | 4 | 89 | 2 | 21347284 | |
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 19706030 | ||
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 16149052 | ||
| Pubmed | The IKr drug response is modulated by KCR1 in transfected cardiac and noncardiac cell lines. | 3.87e-05 | 4 | 89 | 2 | 14525949 | |
| Pubmed | Allele-specific demethylation at an imprinted mammalian promoter. | 3.87e-05 | 4 | 89 | 2 | 17942418 | |
| Pubmed | AC3-33, a novel secretory protein, inhibits Elk1 transcriptional activity via ERK pathway. | 3.87e-05 | 4 | 89 | 2 | 20680465 | |
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 7983737 | ||
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 26187182 | ||
| Pubmed | Tenascin-C promotes melanoma progression by maintaining the ABCB5-positive side population. | 3.87e-05 | 4 | 89 | 2 | 20729912 | |
| Pubmed | Probing nuclear pore complex architecture with proximity-dependent biotinylation. | 4.70e-05 | 77 | 89 | 4 | 24927568 | |
| Pubmed | 6.44e-05 | 5 | 89 | 2 | 14676217 | ||
| Pubmed | Genome- and phenome-wide analyses of cardiac conduction identifies markers of arrhythmia risk. | 6.44e-05 | 5 | 89 | 2 | 23463857 | |
| Pubmed | Distinct contributions of partial and full EMT to breast cancer malignancy. | 6.44e-05 | 5 | 89 | 2 | 34847378 | |
| Pubmed | 6.44e-05 | 5 | 89 | 2 | 23872634 | ||
| Pubmed | Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping. | 6.44e-05 | 5 | 89 | 2 | 11401426 | |
| Pubmed | Early development of electrical excitability in the mouse enteric nervous system. | 6.44e-05 | 5 | 89 | 2 | 22875929 | |
| Pubmed | 6.44e-05 | 5 | 89 | 2 | 10402467 | ||
| Pubmed | Pain-causing stinging nettle toxins target TMEM233 to modulate NaV1.7 function. | 6.44e-05 | 5 | 89 | 2 | 37117223 | |
| Pubmed | 6.44e-05 | 5 | 89 | 2 | 20011526 | ||
| Pubmed | 6.44e-05 | 5 | 89 | 2 | 8388392 | ||
| Pubmed | Genetic variation in T-box binding element functionally affects SCN5A/SCN10A enhancer. | 6.44e-05 | 5 | 89 | 2 | 22706305 | |
| Pubmed | 6.44e-05 | 5 | 89 | 2 | 15664519 | ||
| Pubmed | 9.65e-05 | 6 | 89 | 2 | 16029194 | ||
| Pubmed | 9.65e-05 | 6 | 89 | 2 | 23711479 | ||
| Pubmed | 9.65e-05 | 6 | 89 | 2 | 17519976 | ||
| Pubmed | 9.65e-05 | 6 | 89 | 2 | 30568254 | ||
| Pubmed | 9.65e-05 | 6 | 89 | 2 | 17256754 | ||
| Pubmed | 9.99e-05 | 35 | 89 | 3 | 18498732 | ||
| Pubmed | 1.35e-04 | 7 | 89 | 2 | 10570282 | ||
| Pubmed | 1.35e-04 | 7 | 89 | 2 | 15272007 | ||
| Pubmed | 1.35e-04 | 7 | 89 | 2 | 20179103 | ||
| Pubmed | 1.35e-04 | 7 | 89 | 2 | 33990333 | ||
| Pubmed | 1.35e-04 | 7 | 89 | 2 | 23139255 | ||
| Pubmed | Pain without nociceptors? Nav1.7-independent pain mechanisms. | 1.35e-04 | 7 | 89 | 2 | 24440715 | |
| Pubmed | 1.35e-04 | 7 | 89 | 2 | 23575686 | ||
| Pubmed | 1.79e-04 | 8 | 89 | 2 | 25101983 | ||
| Pubmed | 1.79e-04 | 8 | 89 | 2 | 19623611 | ||
| Pubmed | Loss of cell adhesion causes hydrocephalus in nonmuscle myosin II-B-ablated and mutated mice. | 1.79e-04 | 8 | 89 | 2 | 17429076 | |
| Pubmed | Sprouty1 is a critical regulator of GDNF/RET-mediated kidney induction. | 1.79e-04 | 8 | 89 | 2 | 15691764 | |
| Pubmed | LMF2 PEX16 NUP133 SLC7A5 DGKE EXT2 PRKDC PSME2 IL6ST SLC27A4 EHD4 | 1.95e-04 | 1168 | 89 | 11 | 19946888 | |
| Pubmed | 1.99e-04 | 44 | 89 | 3 | 35293971 | ||
| Pubmed | 2.30e-04 | 9 | 89 | 2 | 25615698 | ||
| Pubmed | A cell-intrinsic role for TLR2-MYD88 in intestinal and breast epithelia and oncogenesis. | 2.30e-04 | 9 | 89 | 2 | 25362351 | |
| Pubmed | 2.30e-04 | 9 | 89 | 2 | 22410172 | ||
| Pubmed | Sodium channel Scn1b null mice exhibit prolonged QT and RR intervals. | 2.30e-04 | 9 | 89 | 2 | 17884088 | |
| Pubmed | 2.30e-04 | 9 | 89 | 2 | 14530346 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | EDEM3 LMF2 GRAMD1A NADK SLC7A5 TMEM214 EXT2 PSME2 CDH2 CTSZ IL6ST | 2.47e-04 | 1201 | 89 | 11 | 35696571 |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | LMF2 GRAMD1A PEX16 SLC7A5 DGKE TMEM214 EXT2 PRKDC CDH2 TBL3 SLC27A4 | 2.51e-04 | 1203 | 89 | 11 | 29180619 |
| Pubmed | Developmental and cell-specific expression of thyroid hormone transporters in the mouse cochlea. | 2.88e-04 | 10 | 89 | 2 | 21878515 | |
| Pubmed | TGFβ pathway is required for viable gestation of Fanconi anemia embryos. | 2.88e-04 | 10 | 89 | 2 | 36441774 | |
| Pubmed | Seven genes from human chromosome 18 map to chromosome 24 in the bovine. | 2.88e-04 | 10 | 89 | 2 | 8697804 | |
| Pubmed | A point mutation in Myh10 causes major defects in heart development and body wall closure. | 2.88e-04 | 10 | 89 | 2 | 24825879 | |
| Pubmed | LMO7 CORO2A GRAMD1A NUP133 SLC7A5 DGKE PRKDC PSME2 UNC45A SPECC1 SLC27A4 EHD4 | 3.02e-04 | 1440 | 89 | 12 | 30833792 | |
| Pubmed | 3.27e-04 | 52 | 89 | 3 | 22632162 | ||
| Pubmed | 3.51e-04 | 11 | 89 | 2 | 32367046 | ||
| Pubmed | 3.51e-04 | 11 | 89 | 2 | 14645112 | ||
| Pubmed | 3.51e-04 | 11 | 89 | 2 | 19622544 | ||
| Pubmed | 3.51e-04 | 11 | 89 | 2 | 26906157 | ||
| Pubmed | The endocytic recycling regulatory protein EHD1 Is required for ocular lens development. | 3.51e-04 | 11 | 89 | 2 | 26455409 | |
| Cytoband | 1q23.3 | 1.22e-04 | 49 | 89 | 3 | 1q23.3 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 3.03e-06 | 9 | 61 | 3 | 1203 | |
| GeneFamily | Alpha-1,2-glucosyltransferases | 1.12e-05 | 2 | 61 | 2 | 448 | |
| ToppCell | Ciliated_cells-B-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 3.65e-07 | 149 | 83 | 6 | 6399c5a2f06d79f020dece252526f1c0c110d569 | |
| ToppCell | Ciliated_cells-A-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 5.34e-07 | 159 | 83 | 6 | 0c65ae6140abd48c79b04758a6217709ddd15385 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.43e-06 | 135 | 83 | 5 | 8521107817df49efd9a2e81078c8535ed33e729c | |
| ToppCell | Control-Myeloid-Dendritic_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.19e-06 | 143 | 83 | 5 | bb8d4c335682d1a6798bed0de8bb0603054a4944 | |
| ToppCell | Control-Myeloid-Dendritic_cells-pDC|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.69e-06 | 145 | 83 | 5 | bab85a72142b6257f7d424e5301f65b6dcdf745d | |
| ToppCell | Ciliated_cells-A-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 1.03e-05 | 154 | 83 | 5 | 3b938e23324f7edb56797b4a76fb96ff588142cf | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.03e-05 | 154 | 83 | 5 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.03e-05 | 154 | 83 | 5 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-dnT|ICU-SEP / Disease, Lineage and Cell Type | 1.48e-05 | 166 | 83 | 5 | 96d92316cee20b722fe782db9dafcceb8f2c220b | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 171 | 83 | 5 | 913bae728b5e653771a27c79a309eb023699f1d0 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 171 | 83 | 5 | f28b2336057e353b96a6ff4581ec9fd0ca0789d9 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.71e-05 | 171 | 83 | 5 | 846a9acfff0bf0a9baf65dc07b7d7a9217ed6598 | |
| ToppCell | facs-BAT-Fat-18m-Lymphocytic-T_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-05 | 175 | 83 | 5 | bf1ef77d5fed2135ac83a4f7e445ab59d1538696 | |
| ToppCell | Ciliated_cells-A-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 2.07e-05 | 178 | 83 | 5 | 255473ee6df8a13079fb3bb61038162a40cb4c2c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.13e-05 | 179 | 83 | 5 | 06d412fc096d88de168969466ce422f0ab5553b2 | |
| ToppCell | Healthy_donor-MAIT|Healthy_donor / disease group, cell group and cell class (v2) | 2.31e-05 | 182 | 83 | 5 | ac7c83464487ecde3df6804a99551307bd768f21 | |
| ToppCell | Ciliated_cells-B-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 2.49e-05 | 185 | 83 | 5 | 4fc7113d3dadc716ec5a8e62b58543cc00ce5b16 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.76e-05 | 189 | 83 | 5 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | distal-Epithelial-Proximal_Ciliated|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.21e-05 | 195 | 83 | 5 | abe7998421dc59bdae35c0c2251c4a1ebef5e021 | |
| ToppCell | distal-Epithelial-Proximal_Ciliated-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.21e-05 | 195 | 83 | 5 | 0e3f74e0877d33c11f048b9be8394596cf5c9c4c | |
| ToppCell | COVID-19-Epithelial|COVID-19 / Condition, Lineage and Cell class | 3.37e-05 | 197 | 83 | 5 | 18fd7344628a87d5c7ef5efb66e260a4136245bf | |
| ToppCell | distal-3-Epithelial-Proximal_Ciliated|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.37e-05 | 197 | 83 | 5 | 15b4d1203943ce90a7083178d4a4284d9b323071 | |
| ToppCell | mLN-T_cell-Th1|mLN / Region, Cell class and subclass | 3.45e-05 | 198 | 83 | 5 | 7627b7c3a248da2bd5e1e6f7c226e5fd0bc92113 | |
| ToppCell | mLN-(1)_T_cell-(12)_Th1|mLN / shred on region, Cell_type, and subtype | 3.45e-05 | 198 | 83 | 5 | 1fe8257233232b264b9ca630c2d92c509a195353 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.53e-05 | 199 | 83 | 5 | 1ee4010d8557564e25e8ee00b914c2dfd9037838 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.53e-05 | 199 | 83 | 5 | 1df69c0cb5f759f6a2152521842506a75bb95cae | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.53e-05 | 199 | 83 | 5 | 92778939e9d06599c7d06cfd8f4362b97ed0606b | |
| ToppCell | Mild-Epithelial-Epithelial-|Mild / Condition, Lineage, Cell class and cell subclass | 3.53e-05 | 199 | 83 | 5 | 81115bbd2c10bfdd38376d2075f03a59c31870d2 | |
| ToppCell | BAL-Mild-Epithelial|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.53e-05 | 199 | 83 | 5 | 74087b4b5e567310fc4ac58fb267ff651a180680 | |
| ToppCell | BAL-Mild-Epithelial|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.53e-05 | 199 | 83 | 5 | 00b5ce099c50a5e1786ce2b3a06ee0931a8205a4 | |
| ToppCell | Mild-Epithelial|Mild / Condition, Lineage, Cell class and cell subclass | 3.53e-05 | 199 | 83 | 5 | ec5fff80e2a8a94fbaf1fdcc6d45c8d7c6252e18 | |
| ToppCell | Mild-Epithelial-Epithelial|Mild / Condition, Lineage, Cell class and cell subclass | 3.53e-05 | 199 | 83 | 5 | 91308b255783ad4029e5575028c18d7550832c51 | |
| ToppCell | Mild_COVID-19-Epithelial|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 3.53e-05 | 199 | 83 | 5 | 72689bda7476930887ae007682fcab27f956f050 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.62e-05 | 200 | 83 | 5 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | Biopsy_Other_PF-Epithelial-Differentiating_Ciliated|Biopsy_Other_PF / Sample group, Lineage and Cell type | 3.62e-05 | 200 | 83 | 5 | f7b4581d958afbd68f9045af619aaca0ab463439 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.62e-05 | 200 | 83 | 5 | da12821e8a0657869ca0f75d351cce2d7605a505 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.62e-05 | 200 | 83 | 5 | e1da1b15d2ca06796ee1ab7cef586ae0b4dc0a0a | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.62e-05 | 200 | 83 | 5 | 72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Vipr2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.28e-05 | 119 | 83 | 4 | 6425425b2e622c97b6c74c530ccbfe394d3b202d | |
| ToppCell | Lymphoid-NK_cells|World / shred on cell class and cell subclass (v4) | 1.06e-04 | 131 | 83 | 4 | b0b62392d1637601115e85f5584fdcd5dbd0c778 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.44e-04 | 142 | 83 | 4 | efe2418436ad1320b8e8fce38619ac65516ef077 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.48e-04 | 143 | 83 | 4 | 138033ff447a61a1bc289b21db82151dcc6a4c7e | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.52e-04 | 144 | 83 | 4 | 1c001a5a3bbe4ecbce8305f8b260e933033550dd | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Sphkap|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.56e-04 | 56 | 83 | 3 | af55596513ddbe60b08648b27e41a7b65e3da58c | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.60e-04 | 146 | 83 | 4 | 45d7cb73776e60d22f335a651845e21e16948fcc | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.69e-04 | 148 | 83 | 4 | 3aa47398cb805c6c6e16b375cc3e9c7f04bb91f4 | |
| ToppCell | Control-Lymphocytic_NKT-iNKT/MAIT-T-cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.69e-04 | 148 | 83 | 4 | 003e10bf477984248211b99d75daa8f7dcdb12c8 | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.69e-04 | 148 | 83 | 4 | d61123f0c811287843d066b932b4a9ff09c07c5b | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.69e-04 | 148 | 83 | 4 | c8e93b87212f55774223caa385859c566fa1981f | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.82e-04 | 151 | 83 | 4 | 1525422afadff68a1525ced6d5db45fdea450678 | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.82e-04 | 151 | 83 | 4 | 81cf939ed4df9574fbfff265e109cb9f947d7e6e | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.82e-04 | 151 | 83 | 4 | 9cbcbbc22965a9f0be8364e733d205dd64f2a533 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.87e-04 | 152 | 83 | 4 | ed6df77ba04b715e12c2e1591b4a1e894ca49d25 | |
| ToppCell | mild_COVID-19_(asymptomatic)-MAIT|World / disease group, cell group and cell class (v2) | 1.92e-04 | 153 | 83 | 4 | 2b4c69f6db17927d6506a645ac058133e60b0103 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-Klrb1a/b/c(-)_NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-04 | 153 | 83 | 4 | cb144b8c487286384b47fdff88ff98fcf0508899 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.02e-04 | 155 | 83 | 4 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.02e-04 | 155 | 83 | 4 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD8-Trm/em_CD8|GI_large-bowel / Manually curated celltypes from each tissue | 2.12e-04 | 157 | 83 | 4 | d85304af4cd3b8aaedc5362a8223537e1b9dbec2 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pou6f2-Inhibitory_Neuron.Gad1Gad2.Pou6f2-Pax6_(Zona_incerta_(ZI))|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.12e-04 | 62 | 83 | 3 | 02f0398e18bd61fbfa03bce71ae77e106181abee | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pou6f2-Inhibitory_Neuron.Gad1Gad2.Pou6f2-Pax6_(Zona_incerta_(ZI))-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.12e-04 | 62 | 83 | 3 | 8fdbced7a2baa1bfb5b1e204128234424a872fe6 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pou6f2|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.12e-04 | 62 | 83 | 3 | ff68e007b8b2af4c7fb09139aed92e86907a05da | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.22e-04 | 63 | 83 | 3 | 55f11bb2970a8159166e71af34a0446ecee594e6 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Granulocytic-Mast_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.27e-04 | 160 | 83 | 4 | fe9970c160159b35f6599ed13c89cfb49264d554 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Chat-Inhibitory_Gad1Gad2Chat_Htr3a.Chat_(Interneuron,_Cholinergic_(candidate__CGE-derived_2))|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.33e-04 | 64 | 83 | 3 | bbce496e9682cd74e3163a64d9d20bc6368d3e48 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Chat-Inhibitory_Gad1Gad2Chat_Htr3a.Chat_(Interneuron,_Cholinergic_(candidate__CGE-derived_2))-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.33e-04 | 64 | 83 | 3 | 91371907b75b0b97d2ebd57d4048a81f5e5fd694 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Chat|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.33e-04 | 64 | 83 | 3 | 3e464bd87c15ba34c174e11fbe8d88e9a8735caf | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_12|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.33e-04 | 161 | 83 | 4 | 1670108afc0af90861eb80a84e59995571c0da1b | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_12|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.33e-04 | 161 | 83 | 4 | 1d446f5ba57d84949823a35cbedaee8f448fe40f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c02-NCAM1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.44e-04 | 163 | 83 | 4 | 1c014e373667be290d7fb5d24c06c6f313ac8fa3 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-Tfh|bone_marrow / Manually curated celltypes from each tissue | 2.62e-04 | 166 | 83 | 4 | 9ac5267d3a53a96dec9eae3bc01acba4750742c8 | |
| ToppCell | Severe-Lymphoid-NK-innate_T|Severe / Condition, Lineage, Cell class and cell subclass | 2.62e-04 | 166 | 83 | 4 | ee5ee75131fc0e22da0ceba3917f2104516af4b7 | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC2-cDC2_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.74e-04 | 168 | 83 | 4 | b7cd33f5da4f37b9384fc3bd3ca01fbc790accfc | |
| ToppCell | 3'_v3-Lung-Lymphocytic_Invariant-Inducer-like|Lung / Manually curated celltypes from each tissue | 2.74e-04 | 168 | 83 | 4 | b9bde6f542d730682d34a80e1f7f1609e5c699c7 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-04 | 169 | 83 | 4 | 4e1322cc5e1733e9fb19e08f739a30206f43cea8 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-04 | 170 | 83 | 4 | 90f7640f04672c800cb28aea50004b1bb0565e8a | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-04 | 170 | 83 | 4 | 75b0486620cab838d3feb1c3aa965b487a906618 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.87e-04 | 170 | 83 | 4 | da4dde7d0491ccc298cec7474a6a76ff3db36a4c | |
| ToppCell | Substantia_nigra-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Shox2_(peripeduncular_nucleus_&_posterior_intralaminar_thalamic_nucleus_(PP_&_PIL))|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.91e-04 | 69 | 83 | 3 | 72031d97bf3a3f3e8fe2ad1130c766e39b3b4c46 | |
| ToppCell | Substantia_nigra-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Shox2_(peripeduncular_nucleus_&_posterior_intralaminar_thalamic_nucleus_(PP_&_PIL))-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.91e-04 | 69 | 83 | 3 | 20bda1222efe784b025c6b311a7813b3b562ec71 | |
| ToppCell | 368C-Lymphocytic-ILC|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.93e-04 | 171 | 83 | 4 | 3b3143e4aa6520ee9c6b6f2482206ad3d8205d14 | |
| ToppCell | facs-Marrow-Granulocytes|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-04 | 171 | 83 | 4 | 1701dedf0c18751db6c9fee3d93fff150ed0e17f | |
| ToppCell | 368C-Lymphocytic-ILC-ILC-2|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.93e-04 | 171 | 83 | 4 | fd01076574dcc82bfd4a1538812500543b16794f | |
| ToppCell | Healthy/Control-MAIT|World / Disease group and Cell class | 2.93e-04 | 171 | 83 | 4 | 61515114b17816a8f9ef6a57262eb9e977b6ede4 | |
| ToppCell | Healthy_donor-MAIT|World / disease group, cell group and cell class (v2) | 3.00e-04 | 172 | 83 | 4 | 6524eb2be1c78700ad367e62624a4d7eb48b54f0 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-04 | 172 | 83 | 4 | d354424c1f861b6607dfd63b9724f4c237b30275 | |
| ToppCell | Healthy/Control-MAIT|Healthy/Control / Disease group and Cell class | 3.06e-04 | 173 | 83 | 4 | 56247c1e07477a8922fe2e3950ae05e2217fd77c | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.20e-04 | 175 | 83 | 4 | 96219e58dcb327fd27190be78193e7a0d611e62b | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.20e-04 | 175 | 83 | 4 | cb974fbebe8cb58c7d3f7defabb4e056f2fee5fa | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.20e-04 | 175 | 83 | 4 | ae7e0448ffd11b8908d0f6d99ff737faf5eca4bf | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.27e-04 | 176 | 83 | 4 | 87de432c680b80555342afac864599bbc002c040 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.27e-04 | 176 | 83 | 4 | 1df7b6ce2519ad99bacbbaf1a8d5929e11513faa | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.27e-04 | 176 | 83 | 4 | 90f8bb11f339f67f08692a0c33dd420f5cda2861 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.34e-04 | 177 | 83 | 4 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | Control-T/NK-NK|Control / Disease group,lineage and cell class (2021.01.30) | 3.41e-04 | 178 | 83 | 4 | 079fd19bdeed86bf985c4083af432432d66ad546 | |
| ToppCell | Ciliated_cells-A-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 3.48e-04 | 179 | 83 | 4 | 1c41314b6fcfcac8d62034e7037570120d58f20f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.48e-04 | 179 | 83 | 4 | 58ae5a97fe2a14e1c6fdeb886397eb06fdaf0428 | |
| ToppCell | 368C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.56e-04 | 180 | 83 | 4 | eb5a57604c7f2ad256c300085dbf5069d0ae1ad0 | |
| ToppCell | 368C-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.56e-04 | 180 | 83 | 4 | ddba4dc3bbcfe4e4a22400be73bbc62d3ff27d3c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.63e-04 | 181 | 83 | 4 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.63e-04 | 181 | 83 | 4 | 071f9bb5d39070cdc473d9b0e094d196bc702b56 | |
| Drug | Cocaine | 2.68e-06 | 8 | 84 | 3 | DB00907 | |
| Drug | 3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Up 200; 13.8uM; PC3; HT_HG-U133A | 7.88e-06 | 195 | 84 | 7 | 4298_UP | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 2.19e-06 | 10 | 79 | 3 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 2.19e-06 | 10 | 79 | 3 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 3.99e-06 | 12 | 79 | 3 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Long Qt Syndrome 2 | 2.12e-05 | 3 | 79 | 2 | C3150943 | |
| Disease | PAROXYSMAL EXTREME PAIN DISORDER | 2.12e-05 | 3 | 79 | 2 | C1833661 | |
| Disease | Primary Erythermalgia | 2.12e-05 | 3 | 79 | 2 | C0014805 | |
| Disease | Brugada ECG Pattern | 4.23e-05 | 4 | 79 | 2 | C1721096 | |
| Disease | leptin measurement | 6.77e-05 | 81 | 79 | 4 | EFO_0005000 | |
| Disease | nonsyndromic deafness (implicated_via_orthology) | 1.05e-04 | 6 | 79 | 2 | DOID:0050563 (implicated_via_orthology) | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 5 | 1.47e-04 | 7 | 79 | 2 | C0020075 | |
| Disease | electrocardiography, PR interval | 1.47e-04 | 7 | 79 | 2 | EFO_0004327, EFO_0004462 | |
| Disease | Congenital Pain Insensitivity | 1.47e-04 | 7 | 79 | 2 | C0002768 | |
| Disease | supraventricular ectopy | 2.52e-04 | 9 | 79 | 2 | EFO_0009277 | |
| Disease | PR interval | 3.67e-04 | 495 | 79 | 7 | EFO_0004462 | |
| Disease | Congenital long QT syndrome | 3.83e-04 | 11 | 79 | 2 | cv:C1141890 | |
| Disease | intraocular pressure measurement | 4.33e-04 | 509 | 79 | 7 | EFO_0004695 | |
| Disease | Long QT syndrome | 4.59e-04 | 12 | 79 | 2 | cv:C0023976 | |
| Disease | Brugada Syndrome 1 | 5.42e-04 | 13 | 79 | 2 | C4551804 | |
| Disease | Schizophrenia | ST6GALNAC1 A1BG RAPGEF6 ABCA13 PIK3CB ERVK-8 MAPK3 IL18R1 DNMT3L | 5.84e-04 | 883 | 79 | 9 | C0036341 |
| Disease | T wave morphology measurement | 6.31e-04 | 14 | 79 | 2 | EFO_0008398 | |
| Disease | resting heart rate | 6.99e-04 | 149 | 79 | 4 | EFO_0004351 | |
| Disease | P wave duration | 7.27e-04 | 15 | 79 | 2 | EFO_0005094 | |
| Disease | Romano-Ward Syndrome | 8.29e-04 | 16 | 79 | 2 | C0035828 | |
| Disease | epilepsy (implicated_via_orthology) | 9.77e-04 | 163 | 79 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | Brugada syndrome | 1.18e-03 | 19 | 79 | 2 | MONDO_0015263 | |
| Disease | neutrophil percentage of leukocytes | 1.25e-03 | 610 | 79 | 7 | EFO_0007990 | |
| Disease | Mechanical Allodynia | 1.51e-03 | 84 | 79 | 3 | C2936719 | |
| Disease | Allodynia | 1.51e-03 | 84 | 79 | 3 | C0458247 | |
| Disease | Hyperalgesia, Secondary | 1.51e-03 | 84 | 79 | 3 | C0751212 | |
| Disease | Hyperalgesia, Primary | 1.51e-03 | 84 | 79 | 3 | C0751211 | |
| Disease | Hyperalgesia, Thermal | 1.51e-03 | 84 | 79 | 3 | C0751214 | |
| Disease | Tactile Allodynia | 1.51e-03 | 84 | 79 | 3 | C0751213 | |
| Disease | Hyperalgesia | 1.51e-03 | 84 | 79 | 3 | C0020429 | |
| Disease | Brugada Syndrome (disorder) | 1.88e-03 | 24 | 79 | 2 | C1142166 | |
| Disease | maximal oxygen uptake measurement | 2.21e-03 | 26 | 79 | 2 | EFO_0004887 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NVLPKVLGRSTLWKL | 256 | Q8N6Q1 | |
| LALIQITTSKPVRKW | 216 | Q8IWZ6 | |
| WRVPLTTKTNKTKGL | 36 | Q9NX77 | |
| SPEIKLKWTSSIAQL | 1356 | Q8TER5 | |
| LLESTNTKLWPLKLT | 131 | Q96P56 | |
| NTKLWPLKLTLEVAA | 136 | Q96P56 | |
| NIKRKGAWPSTLLSV | 106 | Q9UBR2 | |
| QSSKLAAKWPTKLVK | 351 | Q9UJW3 | |
| VKGWKLTLVTLSTSP | 201 | Q2M3G0 | |
| KKATPIKLIWSLVAL | 186 | P49685 | |
| LTKKYQTWIKSNLVP | 246 | P49863 | |
| LLSASTRAWKPQSKL | 931 | Q5M775 | |
| LLLFASIKAPQWTKK | 3936 | Q86UQ4 | |
| LLSPSKIKTFLSLVW | 306 | Q5I7T1 | |
| VGTKTKLSTLTLLWP | 271 | Q7L2E3 | |
| TQIAWPSKLKIGAKS | 86 | Q9H694 | |
| KQPWSLVKSLIEKNS | 501 | Q96CP6 | |
| STKKAEPLTWAQLKK | 41 | P61576 | |
| SIWPSAKILTQVSKL | 861 | Q6ZRR7 | |
| WTQLSKLLELTGPKS | 101 | P04217 | |
| WKIALSPITKLSVCK | 126 | Q8WUM0 | |
| PQSLKLLKSHRVLKW | 486 | Q13478 | |
| PATIIWTLNGKTLKT | 1126 | Q15746 | |
| LPWSLTSLKAKVPII | 301 | A6NEK1 | |
| LPLWLSTTNQSISKK | 496 | Q9BZQ6 | |
| EWKTLPSSLLKLNQL | 71 | Q96DD0 | |
| QRLTWNKSPKSVLVI | 96 | O95544 | |
| QKLLSIIKSQGWLPL | 76 | Q6ZU69 | |
| KRSTNTLKKWLTSPV | 1761 | O60229 | |
| FQFLKLTTWILPKIT | 441 | P63132 | |
| KPKWLLQGIFSTTVL | 481 | Q01650 | |
| LTRKIQSWKLGTTVP | 641 | Q8WWI1 | |
| TSKLPNSVLGKIWKL | 476 | Q9H223 | |
| LQSLPSKTKVAWAKL | 281 | P27361 | |
| KWTTPQEIKQKIQLL | 546 | O15553 | |
| QKLLLITSTTPQWKK | 566 | Q8WVZ9 | |
| FQFLKLTTWILPKIT | 441 | P63135 | |
| FQFLKLTTWILPKIT | 441 | Q9BXR3 | |
| FQFLKLTTWILPKIT | 441 | Q9QC07 | |
| LSSILKLTWTNPSIK | 236 | P40189 | |
| KLTWTNPSIKSVIIL | 241 | P40189 | |
| KSLKTLSAELVPWLN | 411 | Q8NHQ1 | |
| TIKIWSIPKQLLTRN | 106 | Q92828 | |
| LQKEKLLWPISLSSA | 71 | Q5U5Z8 | |
| TGKAWLQKELKPSQL | 126 | Q6P1S2 | |
| SLTKWIQKNPDLLKA | 91 | Q5VTH2 | |
| LQKKPNWATAKLLLS | 2386 | Q0VDD8 | |
| ETITKNIKWLEKNLP | 936 | Q6P179 | |
| SKLGKQWTPLIILAN | 211 | P52429 | |
| LAKTWSTNLANIKLP | 31 | Q96KX1 | |
| LKPNLKVNLWKSDSS | 816 | Q9Y2H2 | |
| TKVDSIAWKKLLPSQ | 46 | Q9BZW8 | |
| TQEKWQVAVKLSLKP | 111 | P19022 | |
| QKLLLITSRTPQWKK | 566 | Q86V97 | |
| SWVKTQTKGKIPNLL | 171 | P05120 | |
| KKLPVSLSQQKLLTW | 71 | Q9Y5Y5 | |
| LWNLQKTVPAKKSAS | 506 | Q13033 | |
| WTLLKPSLIKCLAVS | 1326 | Q8TEU7 | |
| DKQSKWSGIPQLLLK | 66 | Q8TEL6 | |
| KKTATSWPKALLATL | 301 | Q9BU23 | |
| KIPLAKTTLEKTWLF | 386 | Q96NG3 | |
| KAILKSLPVWAISTG | 256 | Q14916 | |
| FKLAKSWPTLNTLIK | 816 | Q14524 | |
| TITNIPKLKASWRQL | 401 | Q8TBK2 | |
| KASKSLWLQKLFLPN | 286 | Q9NSC7 | |
| LSLLALVKPEVWTLK | 101 | Q9UL46 | |
| QSLPKLLLSIKWNKL | 571 | P42338 | |
| LLSPSKIKTFLSLVW | 306 | Q5BKT4 | |
| FQFLKLTTWILPKIT | 441 | P63136 | |
| SKSVISLLEKRKLPW | 16 | Q5EBM4 | |
| TSQVLSKWDPIILKN | 136 | Q5TAP6 | |
| KVKLDLWLKTLSPEN | 281 | P0CB47 | |
| SPVWKTLQKIKLNSD | 161 | Q5VVC0 | |
| LSTLTGVWKKLIPTL | 396 | Q96MW7 | |
| LLFSKLVLKLPWTQV | 11 | Q6P1M0 | |
| AGSPSKTKLTWLLSI | 231 | P49675 | |
| LKPLLSNEVIWLDSK | 201 | O95235 | |
| LAKSWPTLNTLIKII | 766 | Q9Y5Y9 | |
| VKLWPLPKALLSKNT | 446 | Q12788 | |
| VSKVPSLSKLLVVWN | 476 | Q93063 | |
| FQFLKLTTWILPKIT | 441 | P10266 | |
| LLSSWEQIPKKVQKS | 421 | Q6NUQ4 | |
| FQFLKLTTWILPKIT | 441 | P63133 | |
| IFIWSKLQLKSNPSK | 301 | Q8IZM8 | |
| TTLLNTSPEGWKLLK | 1346 | P78527 | |
| SFIKVLWNILKPLIS | 146 | P85298 | |
| HIWKPTTSSLLIQLK | 216 | Q5JTN6 | |
| LTLLALWLSSKSPTK | 156 | O14863 | |
| KWLALSKTPSALALN | 26 | O96014 | |
| AKSWPTLNTLIKIIG | 681 | Q9UI33 | |
| KDNWSPALTISKVLL | 136 | P51965 | |
| KSLKDPNNSLTLWVI | 326 | Q9H3U1 | |
| LLTPLKLSLEEWSTK | 556 | O94782 | |
| NTWTLKKLPLSLSFL | 256 | P16473 | |
| KKILKTSLPTNTWDG | 641 | Q86W24 |